Forestgets approval for new fibromyalgia drug Savella. The safety and efficacy of Savella was established in two U.S. pivotal Phase III clinical trials involving over 2,000 patients with fibromyalgia, the companies said.

Eli Lillyhanding over 1.42 billion to resolve Zyprexa probes. Eli Lilly and Co said it will pay about $1.42 billion to settle both criminal and civil investigations related to the marketing of its antipsychotic drug Zyprexa and has agreed to plead guilty to one misdemeanor violation of the Food, Drug, and Cosmetic Act.

Live and in-person – the next conference I’ll be attending is the ePharma Summit in Philadelphia, Feb. 9-11. Here’s the scoop.

Like this:

Welcome!

Steve Woodruff
President, Impactiviti

Testimonials

“Steve Woodruff is one of the most “networked” people I’ve found in pharmaceutical training. His communications are always smart and targeted, and I value his professional partnership.” -Jennifer Zinn, Director, Worldwide Marketing, Clinical Laboratory, Ortho Clinical Diagnostics